International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants

2017 • 23,395 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

2008 • 16,541 citations

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

2004 • 9,201 citations

Cancer Incidence in Five Continents

1970 • 8,763 citations

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

2011 • 7,925 citations

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2009 • 7,749 citations

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

2006 • 5,595 citations

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

2010 • 5,268 citations

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2007 • 5,137 citations

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

2007 • 4,320 citations

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

2004 • 4,293 citations

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

2010 • 4,281 citations

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

2009 • 3,957 citations

Fleischner Society: Glossary of Terms for Thoracic Imaging

2008 • 3,945 citations

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

2007 • 3,597 citations

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

2005 • 3,450 citations

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

2008 • 3,092 citations

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

2006 • 3,029 citations

What is “quality of evidence” and why is it important to clinicians?

2008 • 2,889 citations

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

1995 • 2,739 citations

Somatic mutations affect key pathways in lung adenocarcinoma

2008 • 2,653 citations

Early Lung Cancer Action Project: overall design and findings from baseline screening

1999 • 2,484 citations

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

2004 • 2,376 citations

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

2008 • 2,340 citations

Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers

2005 • 2,285 citations

Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer

2005 • 2,139 citations

Gene-expression profiles predict survival of patients with lung adenocarcinoma

2002 • 2,005 citations

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

2004 • 1,894 citations

Pathology and genetics of tumours of the lung , pleura, thymus and heart

2004 • 1,860 citations

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

2009 • 1,805 citations

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

2006 • 1,691 citations

Survival of Patients with Stage I Lung Cancer Detected on CT Screening

2006 • 1,623 citations

Going from evidence to recommendations

2008 • 1,621 citations

Histological Typing of Lung and Pleural Tumours

1999 • 1,538 citations

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

2005 • 1,510 citations

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

2011 • 1,492 citations

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

2008 • 1,366 citations

AJCC Cancer Staging Manual

2010 • 1,259 citations

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

2010 • 1,163 citations

The National Lung Screening Trial: Overview and Study Design

2010 • 1,146 citations

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

2009 • 1,113 citations

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

2008 • 1,112 citations

Characterizing the cancer genome in lung adenocarcinoma

2007 • 1,110 citations

Histologic grading of prostate cancer: A perspective

1992 • 1,059 citations

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

1995 • 1,032 citations

Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases

2000 • 999 citations

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

2007 • 914 citations

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

2011 • 913 citations

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

2009 • 912 citations

Non-Small Cell Lung Cancer

2016 • 873 citations

Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors

2006 • 824 citations

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

2008 • 802 citations

World Cancer Report 2008

2009 • 793 citations

EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

2005 • 792 citations

Management of Lung Nodules Detected by Volume CT Scanning

2009 • 788 citations

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

2004 • 749 citations

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

2008 • 735 citations

KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

2009 • 712 citations

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

2006 • 710 citations

The EML4‐ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type EGFR and KRAS

2009 • 700 citations

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study

2006 • 698 citations

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial

2011 • 693 citations

Systematic Review and Meta-Analysis of Randomized and Nonrandomized Trials on Safety and Efficacy of Video-Assisted Thoracic Surgery Lobectomy for Early-Stage Non–Small-Cell Lung Cancer

2009 • 690 citations

The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

2009 • 686 citations

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

2008 • 675 citations

Invasive Mediastinal Staging of Lung Cancer

2007 • 669 citations

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

2009 • 665 citations

Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer

2007 • 630 citations

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

2004 • 602 citations

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

2005 • 590 citations

Small Pulmonary Nodules: Volumetrically Determined Growth Rates Based on CT Evaluation

2000 • 576 citations

An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations

2006 • 575 citations

A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer

2006 • 573 citations

Growth rate of small lung cancers detected on mass CT screening.

2000 • 556 citations

Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation.

1991 • 523 citations

Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations

2006 • 507 citations

First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

2009 • 501 citations

Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

2008 • 496 citations

Early Lung Cancer Action Project

2001 • 494 citations

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?

2007 • 490 citations

EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

2008 • 465 citations

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset

2009 • 441 citations

Complete resection in lung cancer surgery: proposed definition

2005 • 429 citations

Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway

2009 • 424 citations

A Novel, Highly Sensitive Antibody Allows for the Routine Detection ofALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry

2010 • 423 citations

The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer

2009 • 419 citations

Histological Typing of Lung Tumours

1981 • 415 citations

Initial Diagnosis of Lung Cancer

2007 • 413 citations

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

2001 • 409 citations

Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features

2006 • 398 citations

MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer

2009 • 392 citations

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

2007 • 390 citations

Histological Typing Of Lung Tumors

1968 • 383 citations

Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

2008 • 375 citations

TTF-1 Expression in Pulmonary Adenocarcinomas

2002 • 372 citations

A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

2009 • 372 citations

Peripheral Lung Adenocarcinoma: Correlation of Thin-Section CT Findings with Histologic Prognostic Factors and Survival

2001 • 361 citations

Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.

1998 • 355 citations

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis

2006 • 342 citations

RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

2006 • 338 citations

Micropapillary Component in Lung Adenocarcinoma

2002 • 331 citations

The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition

2008 • 327 citations

Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung Cancer

2009 • 326 citations

Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene

2009 • 324 citations

Anatomic Segmentectomy in the Treatment of Stage I Non-Small Cell Lung Cancer

2007 • 322 citations

Expression Profile–Defined Classification of Lung Adenocarcinoma Shows Close Relationship With Underlying Major Genetic Changes and Clinicopathologic Behaviors

2006 • 319 citations

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

2010 • 316 citations

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

2009 • 315 citations

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies

2009 • 304 citations

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

2008 • 300 citations

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

2000 • 300 citations

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

2008 • 298 citations

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan

2002 • 294 citations

Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma

2005 • 288 citations

Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts

2006 • 287 citations

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

2009 • 284 citations

Five-year Lung Cancer Screening Experience: CT Appearance, Growth Rate, Location, and Histologic Features of 61 Lung Cancers

2007 • 283 citations

Missense mutations of the BRAF gene in human lung adenocarcinoma.

2002 • 283 citations

Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

2000 • 269 citations

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

2002 • 267 citations

EGFR Tyrosine Kinase Domain Mutations Are Detected in Histologically Normal Respiratory Epithelium in Lung Cancer Patients

2005 • 265 citations

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

2004 • 265 citations

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

2008 • 262 citations

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

2009 • 257 citations

Response and Resistance in a Non–Small-Cell Lung Cancer Patient With an Epidermal Growth Factor Receptor Mutation and Leptomeningeal Metastases Treated With High-Dose Gefitinib

2006 • 255 citations

Persistent Pulmonary Nodular Ground-Glass Opacity at Thin-Section CT: Histopathologic Comparisons

2008 • 252 citations

Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases

2002 • 251 citations

Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning

2001 • 245 citations

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

2009 • 240 citations

Subsolid Pulmonary Nodules and the Spectrum of Peripheral Adenocarcinomas of the Lung: Recommended Interim Guidelines for Assessment and Management

2011 • 238 citations

Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing

2011 • 235 citations

Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor Prognosis

2003 • 235 citations

Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer

2009 • 234 citations

Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases

2011 • 231 citations

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

2012 • 227 citations

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

2010 • 222 citations

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

2009 • 221 citations

Value of Thyroid Transcription Factor-1, E-Cadherin, BG8, WT1, and CD44S Immunostaining in Distinguishing Epithelial Pleural Mesothelioma From Pulmonary and Nonpulmonary Adenocarcinoma

2000 • 221 citations

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.

1996 • 216 citations

Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features

2007 • 215 citations

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter

2002 • 214 citations

Clinical Predictors of Metastatic Disease to the Brain from Non–Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases

2007 • 212 citations

Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1

2007 • 212 citations

Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis

2010 • 209 citations

Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: Histopathologic features and their prognostic implications

2008 • 208 citations

Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

2010 • 207 citations

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

2008 • 204 citations

Pulmonary Ground-Glass Nodules: Increase in Mass as an Early Indicator of Growth

2010 • 203 citations

EGFR Mutations in Lung Adenocarcinomas

2008 • 201 citations

Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis

2002 • 195 citations

Atypical Adenomatous Hyperplasia of the Lung: Implications for the Pathogenesis of Peripheral Lung Adenocarcinoma

1999 • 190 citations

Grade of Stromal Invasion in Small Adenocarcinoma of the Lung

2004 • 190 citations

Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung.

1999 • 189 citations

Histology for Pathologists

2008 • 189 citations

Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay

2006 • 189 citations

Thyroid Transcription Factor-1: A Review

2002 • 188 citations

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience

2005 • 186 citations

Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma

2009 • 185 citations

Small Solitary Pulmonary Nodules (≤1 cm) Detected at Population-Based CT Screening for Lung Cancer: Reliable High-Resolution CT Features of Benign Lesions

2003 • 185 citations

The Diagnostic Value of TTF-1, CK 5/6, and p63 Immunostaining in Classification of Lung Carcinomas

2007 • 185 citations

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions

2003 • 180 citations

Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components

2003 • 180 citations

p63 In pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors

2002 • 180 citations

Thyroid transcription factor 1 in pulmonary adenocarcinoma

2004 • 179 citations

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non–small cell lung carcinomas

2009 • 177 citations

Primary Mucinous (So-called Colloid) Carcinomas of the Lung

2004 • 174 citations

CT Findings and Progression of Small Peripheral Lung Neoplasms Having a Replacement Growth Pattern

2003 • 173 citations

FDG PET measurement of the proliferative potential of non-small cell lung cancer.

2000 • 173 citations

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

2008 • 173 citations

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp

2006 • 170 citations

Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction

2004 • 168 citations

Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis

2005 • 166 citations

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

2009 • 166 citations

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

2012 • 166 citations

High-Resolution CT Analysis of Small Peripheral Lung Adenocarcinomas Revealed on Screening Helical CT

2001 • 166 citations

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

2005 • 164 citations

Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years

2002 • 164 citations

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

2003 • 163 citations

Progression of Focal Pure Ground-Glass Opacity Detected by Low-Dose Helical Computed Tomography Screening for Lung Cancer

2004 • 163 citations

Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates

1986 • 163 citations

Differential Diagnosis of Ground-Glass Opacity Nodules

2007 • 161 citations

Bronchioloalveolar Cell Adenomas

1990 • 161 citations

Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter

2000 • 161 citations

Pulmonary Adenocarcinomas With Enteric Differentiation

2005 • 160 citations

Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation Index

2008 • 160 citations

p63 Expression in Lung Carcinoma

2004 • 160 citations

Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography

2003 • 160 citations

EML4-ALK Fusion Gene Assessment Using Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

2010 • 158 citations

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer

2007 • 157 citations

Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung

2004 • 156 citations

Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography

2002 • 156 citations

Pulmonary Ground-Glass Opacity (GGO) Lesions–Large Size and a History of Lung Cancer are Risk Factors for Growth

2008 • 155 citations

[18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung

2008 • 155 citations

Evidence for Common Clonal Origin of Multifocal Lung Cancers

2009 • 154 citations

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

2006 • 151 citations

Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer

2009 • 150 citations

Histologic features are important prognostic indicators in early stages lung adenocarcinomas

2006 • 150 citations

Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers

2009 • 147 citations

Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung

2001 • 147 citations

Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic Significance

2006 • 146 citations

Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma

2008 • 144 citations

p63 and TTF-1 Immunostaining: A Useful Marker Panel for Distinguishing Small Cell Carcinoma of Lung From Poorly Differentiated Squamous Cell Carcinoma of Lung

2003 • 142 citations

Compliance with Fleischner Society Guidelines for Management of Small Lung Nodules: A Survey of 834 Radiologists

2010 • 141 citations

Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung

2001 • 141 citations

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

2000 • 141 citations

The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma

2003 • 140 citations

Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis

2006 • 140 citations

Pulmonary Adenocarcinomas of the Fetal Lung Type

1998 • 140 citations

Mucinous and Nonmucinous Bronchioloalveolar Adenocarcinomas Have Distinct Staining Patterns With Thyroid Transcription Factor and Cytokeratin 20 Antibodies

2001 • 139 citations

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine‐needle aspiration specimens

2009 • 138 citations

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma

2010 • 135 citations

Long-term follow-up study of a population-based 1996–1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography

2007 • 133 citations

Bronchioloalveolar carcinoma: The significance of two histopathologic types

1984 • 133 citations

c‐Met activation in lung adenocarcinoma tissues: An immunohistochemical analysis

2007 • 133 citations

Atypical Adenomatous Hyperplasia and Bronchoalveolar Lung Carcinoma

1996 • 133 citations

Distinctive Evaluation of Nonmucinous and Mucinous Subtypes of Bronchioloalveolar Carcinomas inEGFRand K-rasGene-Mutation Analyses for Japanese Lung Adenocarcinomas

2007 • 131 citations

Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer

2008 • 127 citations

Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers

2010 • 127 citations

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

2006 • 126 citations

High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients.

1999 • 125 citations

Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients

2002 • 124 citations

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung

2008 • 123 citations

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non–small cell lung carcinomas

2006 • 123 citations

Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS)

2009 • 121 citations

Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas

2007 • 121 citations

EGFRMutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry

2010 • 121 citations

Pack‐years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer

2009 • 120 citations

Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

2007 • 119 citations

Bronchioloalveolar Carcinoma of the Lung 3 Centimeters or Less in Diameter: A Prognostic Assessment

2004 • 119 citations

Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours)

2005 • 118 citations

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component

2010 • 118 citations

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

2008 • 117 citations

Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung

2005 • 117 citations

Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form Morules

2002 • 116 citations

Molecular Context of theEGFRMutations: Evidence for the Activation of mTOR/S6K Signaling

2006 • 114 citations

Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers

2009 • 114 citations

Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung

2008 • 112 citations

FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features

2000 • 112 citations

Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

2010 • 112 citations

Survival prediction of stage I lung adenocarcinomas by expression of 10 genes

2007 • 111 citations

Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational Analysis

2009 • 110 citations

BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE

1996 • 110 citations

Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary Spread

2009 • 110 citations

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas

2009 • 110 citations

Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: Comparison with solitary ground-glass opacity nodule

2008 • 109 citations

A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis

2007 • 109 citations

Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non–small cell lung cancer: A large-scale retrospective cohort study applying a propensity score

2009 • 108 citations

Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma

2006 • 103 citations

Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas

2004 • 103 citations

Effect of Varying CT Section Width on Volumetric Measurement of Lung Tumors and Application of Compensatory Equations

2003 • 102 citations

Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma

2008 • 102 citations

Lung Tumor Growth: Assessment with CT—Comparison of Diameter and Cross-sectional Area with Volume Measurements

2004 • 102 citations

Limited Resection for Noninvasive Bronchioloalveolar Carcinoma Diagnosed by Intraoperative Pathologic Examination

2009 • 101 citations

Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study

2008 • 101 citations

Molecular Signatures in Biopsy Specimens of Lung Cancer

2004 • 101 citations

Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings

2001 • 101 citations

Non-Overlapping and Non–Cell-Type–Specific Gene Expression Signatures Predict Lung Cancer Survival

2008 • 100 citations

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers

2007 • 100 citations

Bronchoalveolar carcinoma: Factors affecting survival

1991 • 98 citations

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

2009 • 97 citations

Correlation between morphology and EGFR mutations in lung adenocarcinomas

2008 • 97 citations

True Papillary Carcinoma of the Lung

1997 • 95 citations

Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung

2007 • 95 citations

Expression of Thyroid Transcription Factor-1, Cytokeratin 7, and Cytokeratin 20 in Bronchioloalveolar Carcinomas: an Immunohistochemical Evaluation of 67 Cases

2002 • 94 citations

Alveolar epithelial hyperplasia and adenocarcinoma of the lung.

1990 • 94 citations

Use of Epidermal Growth Factor Receptor/Kirsten Rat Sarcoma 2 Viral Oncogene Homolog Mutation Testing to Define Clonal Relationships Among Multiple Lung Adenocarcinomas

2009 • 94 citations

Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas

2008 • 94 citations

Prognostic significance of [¹⁸F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma

2006 • 93 citations

The Histopathology of BRAF-V600E–mutated Lung Adenocarcinoma

2008 • 93 citations

Precursors to Pulmonary Neoplasia

1998 • 93 citations

Micropapillary Lung Adenocarcinoma

2009 • 92 citations

β‐Catenin mutations in pulmonary blastomas: association with morule formation

2003 • 91 citations

A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular Features, and Possible Pitfalls in Routine Practice

2010 • 90 citations

Monoclonality of Atypical Adenomatous Hyperplasia of the Lung

1999 • 90 citations

Association of HER‐2 overexpression with prognosis in nonsmall cell lung carcinoma: A metaanalysis

2005 • 90 citations

CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas

2004 • 90 citations

High-resolution CT of bronchioloalveolar carcinoma.

1992 • 89 citations

Pulmonary Nodule Volume: Effects of Reconstruction Parameters on Automated Measurements—A Phantom Study

2008 • 88 citations

Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin

2006 • 88 citations

Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized Treatments

2009 • 87 citations

Radiologic–prognostic correlation in patients with small pulmonary adenocarcinomas

2002 • 87 citations

Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma

2010 • 85 citations

Integration of Molecular Profiling into the Lung Cancer Clinic

2009 • 85 citations

Usefulness of Cdx2 in Separating Mucinous Bronchioloalveolar Adenocarcinoma of the Lung From Metastatic Mucinous Colorectal Adenocarcinoma

2004 • 84 citations

Loss of Heterozygosity on Chromosomes 9q and 16p in Atypical Adenomatous Hyperplasia Concomitant with Adenocarcinoma of the Lung

2001 • 83 citations

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

2009 • 83 citations

Computer-Aided Volumetry of Pulmonary Nodules Exhibiting Ground-Glass Opacity at MDCT

2010 • 82 citations

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

2008 • 81 citations

p63 and TTF-1 Immunostaining: A Useful Marker Panel for Distinguishing Small Cell Carcinoma of Lung From Poorly Differentiated Squamous Cell Carcinoma of Lung

2003 • 81 citations

Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons

2008 • 81 citations

Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas

2001 • 80 citations

Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.

2004 • 80 citations

Lobar bronchioloalveolar carcinoma: "angiogram sign" on CT scans.

1990 • 79 citations

Bronchioloalveolar Carcinoma: The Case for Two Diseases

2008 • 79 citations

The Role of Desmoglein-3 in the Diagnosis of Squamous Cell Carcinoma of the Lung

2009 • 78 citations

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

2009 • 78 citations

Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma

2006 • 78 citations

Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-β Receptor as a Repressor of Invasiveness

2005 • 77 citations

Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas

2007 • 77 citations

Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.

1990 • 77 citations

Bronchioloalveolar Carcinoma: A Review

2006 • 76 citations

Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter

2004 • 76 citations

Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator

2010 • 76 citations

Epidermal growth factor receptor mutations in lung cancers

2007 • 75 citations

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

2009 • 75 citations

Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma

2010 • 74 citations

Nuclear grading of primary pulmonary adenocarcinomas

2010 • 74 citations

The spectrum and significance of bronchioloalveolar carcinomas.

1988 • 74 citations

Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage I lung adenocarcinoma

2004 • 74 citations

Non-Small Cell Lung Cancer

2008 • 73 citations

Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.

2002 • 72 citations

Carcinoma of the Lung: Evaluation of Histological Grade and Factors Influencing Prognosis

1982 • 72 citations

Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma

2002 • 72 citations

Predicting Survival within the Lung Cancer Histopathological Hierarchy Using a Multi-Scale Genomic Model of Development

2006 • 72 citations

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.

1998 • 72 citations

Expression of MUC1, MUC2, MUC5AC, and MUC6 in Atypical Adenomatous Hyperplasia, Bronchioloalveolar Carcinoma, Adenocarcinoma With Mixed Subtypes, and Mucinous Bronchioloalveolar Carcinoma of the Lung

2004 • 72 citations

Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival

2009 • 72 citations

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung

2009 • 71 citations

Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer

2007 • 71 citations

Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia

2001 • 71 citations

Early glandular neoplasia of the lung

2000 • 70 citations

Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases

2009 • 70 citations

Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping

2006 • 69 citations

Cell Type Accuracy of Bronchial Biopsy Specimens in Primary Lung Cancer

1996 • 69 citations

Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters

2009 • 69 citations

Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics

2003 • 69 citations

Prognostic Factors in T1 NO MO Adenocarcinomas and Bronchioloalveolar Carcinomas of the Lung

1999 • 69 citations

Dominant Papillary Subtype Is a Significant Predictor of the Response to Gefitinib in Adenocarcinoma of the Lung

2004 • 69 citations

Uncommon V599E BRAF Mutations in Japanese Patients with Lung Cancer

2005 • 68 citations

Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study

2004 • 68 citations

A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity

2006 • 68 citations

Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma

2009 • 67 citations

HISTOLOGICAL TYPING OF LUNG TUMOURS

1968 • 66 citations

Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features

2008 • 66 citations

Prognostic Significance of Thin-Section CT Scan Findings in Small-Sized Lung Adenocarcinoma

2007 • 66 citations

Pulmonary Nodular Ground-Glass Opacities in Patients With Extrapulmonary Cancers

2008 • 65 citations

Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation

1999 • 64 citations

Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less

2007 • 63 citations

The Spectrum of Pulmonary Mucinous Cystic Neoplasia

2005 • 63 citations

p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma

2001 • 63 citations

[F-18]Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA Lung Adenocarcinomas

2006 • 63 citations

CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: pictorial review

2001 • 62 citations

A prognostic test for adenocarcinoma of the lung from gene expression profiling data.

2003 • 62 citations

Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series

2008 • 62 citations

Lung Adenocarcinoma With Bronchioloalveolar Carcinoma Component Is Frequently Associated With Foci of High-Grade Atypical Adenomatous Hyperplasia

2002 • 61 citations

Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung Adenocarcinomas

2005 • 59 citations

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

2006 • 59 citations

Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung

2005 • 59 citations

Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity

2009 • 59 citations

Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration

2005 • 58 citations

Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study

2010 • 58 citations

Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer

2003 • 58 citations

Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features.

2000 • 57 citations

The prognostic significance of ERCC1, BRCA1, XRCC1, and βIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection

2009 • 57 citations

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

2010 • 56 citations

Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival☆

2003 • 56 citations

Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases.

1992 • 55 citations

Primary Pulmonary Adenocarcinoma With Intestinal Differentiation Mimicking Metastatic Colorectal Carcinoma

2008 • 53 citations

FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations

1998 • 52 citations

A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity

2007 • 52 citations

Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors

2007 • 51 citations

Lung adenocarcinoma as a solitary pulmonary nodule: Prognostic determinants of CT, PET, and histopathologic findings

2009 • 49 citations

Prognostic Value of 18F-FDG Uptake on Positron Emission Tomography in Patients with Pathologic Stage I Non-small Cell Lung Cancer

2009 • 48 citations

Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.

2001 • 47 citations

Mucinous (so-called colloid) carcinomas of lung.

1992 • 47 citations

Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: A chromogenic in situ hybridization study of 182 patients

2008 • 46 citations

Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo‐alveolar carcinoma

1990 • 45 citations

Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung

2002 • 44 citations

Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma

2004 • 44 citations

Initial Findings and Progression of Lung Adenocarcinoma on Serial Computed Tomography Scans

2009 • 44 citations

Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

2009 • 44 citations

Postoperative Prognosis in Patients With Non–Small Cell Lung Cancer With Synchronous Ipsilateral Intrapulmonary Metastasis

1997 • 43 citations

Practical approach to patients presenting with multiple synchronous suspect lung lesions

2001 • 43 citations

Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung

2004 • 43 citations

Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma

1999 • 42 citations

High-Resolution CT Features: Prognostic Significance in Peripheral Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Components

2003 • 42 citations

Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types

2004 • 41 citations

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

2009 • 41 citations

Multicentric adenocarcinoma of the lung: CT-pathologic correlation.

1990 • 41 citations

Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: A report of the second case negative for cytokeratin 7

2010 • 41 citations

Possible mechanism of metastasis in lung adenocarcinomas with a micropapillary pattern

2005 • 41 citations

Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients

2008 • 41 citations

Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases

2006 • 39 citations

Subtypes of peripheral adenocarcinoma of the lung: differentiation by thin-section CT

2005 • 39 citations

The Role of Transbronchial Fine Needle Aspiration in an Integrated Care Pathway for the Assessment of Patients with Suspected Lung Cancer

2006 • 38 citations

Bronchioloalveolar Adenocarcinoma of Lung

1998 • 38 citations

Lung Adenocarcinoma Harboring Mutations in the ERBB2 Kinase Domain

2006 • 38 citations

Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: Prognostic factors from CT findings

2010 • 37 citations

Magnetic Resonance Imaging in Peripheral Lung Adenocarcinoma

2009 • 37 citations

Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung

2004 • 37 citations

Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules

2008 • 37 citations

Clinico-Pathological and Biological Significance of Tyrosine Kinase Domain Gene Mutations and Overexpression of Epidermal Growth Factor Receptor for Lung Adenocarcinoma

2006 • 35 citations

Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K-ras gene mutation

2002 • 35 citations

Tumor fluoro-2-deoxy-d-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma

2006 • 35 citations

Differential Expression of Cytokeratins 7 and 20 and Thyroid Transcription Factor-1 in Bronchioloalveolar Carcinoma: An Immunohistochemical Study in Fine-Needle Aspiration Biopsy Specimens

2004 • 35 citations

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma

2007 • 33 citations

Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung

2001 • 33 citations

Measurement of Localized Ground-Glass Attenuation on Thin-Section Computed Tomography Images

2002 • 33 citations

Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers

2009 • 32 citations

Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in Nonsmokers

2008 • 32 citations

Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings

2010 • 32 citations

Clonal Origin of Multiple Lung Cancers

1997 • 32 citations

EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: Investigation of significantly related factors on CT, FDG-PET, and histopathology

2008 • 32 citations

Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer

2009 • 31 citations

Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma

2004 • 31 citations

CT bronchus sign in malignant solitary pulmonary lesions: value in the prediction of cell type

2000 • 31 citations

Differential Expression of Cytokeratins 7 and 20 and Thyroid Transcription Factor-1 in Bronchioloalveolar Carcinoma

2004 • 31 citations

Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study

2009 • 30 citations

Lung adenocarcinomas with micropapillary components

2009 • 29 citations

Adopting helical CT screening for lung cancer

2008 • 29 citations

Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: A baseline and 2-year repeat study

2008 • 29 citations

Mucin-producing Tumor of the Lung

1995 • 28 citations

Survival Trees for Analyzing Clinical Outcome in Lung Adenocarcinomas Based on Gene Expression Profiles: Identification of Neogenin and Diacylglycerol Kinase α Expression as Critical Factors

2005 • 28 citations

Derivation of Stable Microarray Cancer-Differentiating Signatures Using Consensus Scoring of Multiple Random Sampling and Gene-Ranking Consistency Evaluation

2007 • 28 citations

Clinicopathologic Analysis of Multiple (Five or More) Atypical Adenomatous Hyperplasias (AAHs) of the Lung: Evidence for the AAH-Adenocarcinoma Sequence

2010 • 27 citations

Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma.

2006 • 26 citations

Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (

2005 • 25 citations

Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection.

2000 • 24 citations

Omission of mediastinal lymph node dissection in lung cancer: its techniques and diagnostic procedures.

2006 • 23 citations

Comparison of Patient Outcomes According to Histology Among Pemetrexed-Treated Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer in Two Phase II Trials

2010 • 23 citations

Molecular Markers and Changes of Computed Tomography Appearance in Lung Adenocarcinoma with Ground-glass Opacity

2007 • 22 citations

Surgical Resection for Patients With Mucinous Bronchioloalveolar Carcinoma

2010 • 22 citations

Immunohistochemical Analysis of Lung Carcinomas With Pure or Partial Bronchioloalveolar Differentiation

2004 • 22 citations

Ultrasmall Pulmonary Opacities on Multidetector-Row High-Resolution Computed Tomography

2005 • 21 citations

Mucinous Cystadenocarcinoma of the Lung: CT-Pathologic Correlation in Three Cases

1999 • 20 citations

Common and Contrasting Genomic Profiles among the Major Human Lung Cancer Subtypes

2005 • 20 citations

Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias

2008 • 19 citations

Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: Immunohistochemical studies and mutation analysis of the p53 gene

2006 • 19 citations

Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study

2005 • 18 citations

Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.

2003 • 18 citations

Mucin-Producing Adenocarcinoma of the Lung

2005 • 18 citations

Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates.

2008 • 17 citations

Prediction of Lung Adenocarcinoma Without Vessel Invasion

2005 • 15 citations

Correlations of Thin-Section Computed Tomographic, Histopathological, and Clinical Findings of Adenocarcinoma With a Bubblelike Appearance

2010 • 14 citations

Pack years of cigarette smoking as a predictor of survival in 2,013 patients with stage IIIb/IV non-small cell lung cancer (NSCLC)

2008 • 14 citations

Fluorodeoxyglucose Uptake Correlates with the Growth Pattern of Small Peripheral Pulmonary Adenocarcinoma

2006 • 14 citations

High-resolution CT characteristics of poorly differentiated adenocarcinoma of the peripheral lung: comparison with well differentiated adenocarcinoma.

2001 • 13 citations

Proposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease.

2010 • 12 citations

Usefulness of Cdx2 in Separating Mucinous Bronchioloalveolar Adenocarcinoma of the Lung From Metastatic Mucinous Colorectal Adenocarcinoma

2004 • 12 citations

Computed tomographic image comparison between mediastinal and lung windows provides possible prognostic information in patients with small peripheral lung adenocarcinoma

2002 • 10 citations

Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.

2005 • 10 citations

The Ratio of the Maximum High Attenuation Area Dimension to the Maximum Tumor Dimension May Be an Index of the Presence of Lymph Node Metastasis in Lung Adenocarcinomas 3 cm or Smaller on High-Resolution Computed Tomography

2007 • 9 citations

Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

2009 • 6 citations

Optimal sampling methods for margin cytology examination following lung excision☆

2009 • 6 citations

Immunohistochemical, ultrastructural and molecular study of well differentiated adenocarcinomas of the lung predominantly composed of goblet cells

1998 • 5 citations